Gastroenterology 2022: Groundhog Day

Affiliations

¹ Department of Hepatology, Barts Health NHS Trust, London, UK.
² Gastroenterology Department, Guy's and Saint Thomas' NHS Foundation Trust, London, UK.
³ Gastroenterology Department, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.

Editorial

Oliver D Tavabie et al. Frontline Gastroenterol. 2022.

. 2022 Feb 19;13(4):349-351.

doi: 10.1136/flgastro-2022-102111. eCollection 2022.

¹ Department of Hepatology, Barts Health NHS Trust, London, UK.
² Gastroenterology Department, Guy's and Saint Thomas' NHS Foundation Trust, London, UK.
³ Gastroenterology Department, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.

No abstract available

Keywords: COVID-19; health service research.

Conflict of interest statement

Competing interests: All authors are trainee associate editors at Frontline Gastroenterology.

1. Tavabie OD, Clough J. Gastroenterology 2021: from the heart of the COVID-19 pandemic. Frontline Gastroenterol 2021;12:249–51. 10.1136/flgastro-2021-101799 - DOI - PMC - PubMed
1. NHS . Coronavirus (COVID-19) vaccines. NHS, 2022. Available: https://www.nhs.uk/conditions/coronavirus-covid-19/coronavirus-vaccinati... [Accessed 18 Jan 2022].
1. Kennedy NA, Lin S, Goodhand JR, et al. . Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD. Gut 2021;70:1884–93. 10.1136/gutjnl-2021-324789 - DOI - PubMed
1. Davidov Y, Tsaraf K, Cohen-Ezra O, et al. . Immunogenicity and adverse effects of the 2-Dose BNT162b2 messenger RNA vaccine among liver transplantation recipients. Liver Transpl 2022;28:215–23. 10.1002/lt.26366 - DOI - PMC - PubMed
1. Ai J, Wang J, Liu D, et al. . Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study. Clin Gastroenterol Hepatol 2021. 10.1016/j.cgh.2021.12.022. [Epub ahead of print: 20 Dec 2021]. - DOI - PMC - PubMed